Too windy in the desert for climbing, so I'm home to witness the climax of this battle in the mass spec wars:
>>FOSTER CITY, Calif. & TORONTO--(BW HealthWire)--March 15, 2002-- Applied Biosystems (NYSE:ABI - news), an Applera Corporation business, and MDS Inc. (TSE:MDS - news; NYSE:MDZ - news), together with their Applied Biosystems/MDS Sciex Instruments partnership, today announced that the Federal District Court in Wilmington, DE has ruled in favor of Applied Biosystems and MDS Inc. in a patent infringement lawsuit against Micromass U.K. Ltd. and its U.S. subsidiary, Micromass, Inc., both divisions of Waters Corporation. The Micromass Quattro Ultima(TM) systems, including the MassTRANSIT(TM) version introduced in March 2001, were found to infringe U.S. Patent No. 4,963,736. The patent covers technology for triple quadrupole mass spectrometers. The jury awarded damages in the amount of $47.5 million to Applied Biosystems and MDS Inc. The lawsuit was originally filed on February 18, 2000. The court is expected to meet next week to enter the final judgment.
``We are very pleased with the court's ruling today,'' said Michael W. Hunkapiller, Ph.D., President of Applied Biosystems.
``Our scientific leadership in the area of triple quadrupole mass spectrometry is the result of significant investments in research and development made over the last decade. Today's ruling upholds the patents we have developed over this time and our leadership in this technology area,'' said Andy Boorn, Ph.D., President of MDS Sciex.<<
snip
Cheers, Tuck |
